中文
Primary Mobile Navigation
Skip to content
About Us
About
Business Strategy
Managemt Team
Board of Directors
Investors
Therapeutic Areas
Adral Insufficicy
Cystic Fibrosis
Lysosomal Storage Disorders
Osteoporosis
Adrenocortical Tumor
Moderate to Severe Rheumatoid Arthritis
Products & Pipeline
Products
BARUDX, Baricitinib,2mg
SEMEDX,Selumetinib,10mg
BARUDX, Baricitinib,4mg
TEGLIDX，Trelagliptin 100mg
AIVODX，Ivosidenib 250mg
ENASIDX，Enasidenib 100mg
ENTREDX，Entrectinib 200mg
SEPADX，Selpercatinib 40mg
PEMIDX，Pemigatinib 4.5mg
CABODX，Cabozantinib 20/60/80mg
Anticancer
Generic Drugs
Antiviral
Business Developmt
Rare Diseases
Affiliations
Newsroom
New Products
Disease News
Firm News
Locations
Contact Us
Skip to content
About Us
About
Business Strategy
Managemt Team
Board of Directors
Investors
Therapeutic Areas
Adral Insufficicy
Cystic Fibrosis
Lysosomal Storage Disorders
Osteoporosis
Adrenocortical Tumor
Moderate to Severe Rheumatoid Arthritis
Products & Pipeline
Products
BARUDX, Baricitinib,2mg
®
SEMEDX,Selumetinib,10mg
®
BARUDX, Baricitinib,4mg
®
TEGLIDX，Trelagliptin 100mg
®
AIVODX，Ivosidenib 250mg
®
ENASIDX，Enasidenib 100mg
®
ENTREDX，Entrectinib 200mg
®
SEPADX，Selpercatinib 40mg
®
PEMIDX，Pemigatinib 4.5mg
®
CABODX，Cabozantinib 20/60/80mg
®
Anticancer
Generic Drugs
Antiviral
Business Developmt
Rare Diseases
Affiliations
Newsroom
New Products
Disease News
Firm News
Locations
中文
Investors
No external investors have been introduced here
中文